ArticleJournal of virology2022

The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model.

Aswath P Chandrasekar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.